10x Genomics, a medical technology company with impressive revenue growth, ... 10x Genomics: Sales Are Growing At A Rapid Rate, But So Are Expenses. Jan. 20, 2024 2:20 AM ET 10x Genomics, Inc. ...

10x Genomics: Wouldn't Touch This, Even With A 10x10 ... it would have to double revenues every year for the next six years before hitting $15 ... heavy insider selling, mediocre growth rates, ...

Biotech company 10x Genomics (NASDAQ:TXG) reported Q1 CY2025 results , with sales up 9.8% year on year to $154.9 million. On the other hand, next quarter’s revenue guidance of $140 million was ...

We feel now is a pretty good time to analyse 10x Genomics, Inc.'s (NASDAQ:TXG) business as it appears the company may be on the cusp of a considerable accomplishment. 10x Genomics, Inc., a life ...

While 10x Genomics seems to be in a decent position, ... (at the same burn rate). 10x Genomics' cash burn of US$113m is about 2.3% of its US$5.0b market capitalisation.

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell ...

10x Genomics (TXG) could be a ... all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more ...

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made losses for many years after listing, if you had bought and held the shares since ...

10x Genomics has filed an amended up-to-$362.25 million proposed initial public offering (IPO) that would be possibly triple, but no less than double, the size of the offering revealed last month ...